PRICE T ROWE ASSOCIATES INC /MD/
Position in LGND — Ligand Pharmaceuticals Inc
CIK 80255
BALTIMORE, MD
Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,771,834
+$991,948 QoQ
Shares Held
23,901
+19.6% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. LGND ranks #120 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in LGND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,771,834 | 23,901 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,779,886 | 19,992 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,350,602 | 18,915 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,042,602 | 17,968 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,714,622 | 16,308 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,662,753 | 15,518 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,374,936 | 13,737 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,145,177 | 13,591 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $949,714 | 12,992 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $884,321 | 12,382 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $690,398 | 11,522 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $751,137 | 10,418 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $704,925 | 9,583 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $567,532 | 8,496 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $444,623 | 8,277 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $389,217 | 6,993 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $570,379 | 8,128 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $722,868 | 7,502 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $760,132 | 8,746 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $766,516 | 9,366 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $974,329 | 10,245 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,959,262 | 63,818 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $10,495,367 | 176,501 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $20,660,775 | 296,104 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $14,531,375 | 320,322 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||